NCT06126120

Brief Summary

Lynch syndrome, an inherited condition, increases bowel cancer risk. People with Lynch syndrome are recommended to have regular colonoscopies where a camera in a tube is used to look inside the bowel for cancer and for polyps (growths that sometimes can become cancerous). UK guidelines recommend that people with Lynch syndrome have colonoscopy check-up every 2 years after reaching a certain age; however, they face many challenges which make it difficult to have the recommended check-up. Among a subset of people with Lynch syndrome in England, this study investigated the:

  • percentage who underwent colonoscopy check-up as recommended by UK guidelines
  • factors influencing whether a person is more/less likely to have the recommended colonoscopy check-up
  • views, experiences, and challenges of living with Lynch syndrome and undergoing colonoscopy check-up This study collected information from people in the 'Lynch syndrome research registry pilot' using a questionnaire. The Cancer Screening and Prevention Research Group (CSPRG) at Imperial College London set up the Lynch syndrome research registry pilot, which included adults with Lynch syndrome who had previously participated in the Cancer Prevention Programme 3 (CaPP3) trial. The present study included people who took part in the Lynch syndrome research registry pilot, provided consent to be contacted about future research, and were aged ≥25 years. People who had undergone surgery to remove their rectum were excluded. The investigators used the 'Views, experiences, and challenges of colonoscopy check-up questionnaire', together with a few pieces of additional information previously collected as part of the Lynch syndrome research registry pilot. Participation involved completing the questionnaire only. The study was completed over approximately one year from administering the questionnaire in January 2024 to sharing results with participants in December 2024.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
231

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 17, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

June 5, 2026

Completed
Last Updated

June 5, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

November 3, 2023

Results QC Date

March 24, 2026

Last Update Submit

May 13, 2026

Conditions

Keywords

Lynch SyndromeColonoscopySurveillance

Outcome Measures

Primary Outcomes (1)

  • Participant Non-adherence to 2-yearly Colonoscopy Check-up.

    Participant non-adherence to 2-yearly colonoscopy check-up was assessed using data from the national Hospital Episode Statistics (HES) database. Non-adherence was calculated based on the interval(s) between participants' 2 or 3 most recent check-up colonoscopies, depending on data availability, and the interval between participants' most recent check-up colonoscopy and questionnaire completion. Colonoscopy data recorded between December 1995 (when the earliest colonoscopy was recorded in the HES extract) and April 2024 (the final month in which participants completed the questionnaire) were used. Participant non-adherence was reported as a percentage.

    Up to approximately 13 years (median 5 years), based on the interval(s) between participants' 2 or 3 most recent check-up colonoscopies and the interval between participants' most recent check-up colonoscopy and questionnaire completion.

Secondary Outcomes (1)

  • The 4 Most Important Challenges to Having Colonoscopy Check-up for Participants.

    At time of questionnaire (1 day)

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included people who were in the Lynch syndrome research registry pilot and who met the eligibility criteria for the present study.

You may qualify if:

  • People in the Lynch syndrome research registry pilot who provided consent to be contacted about future research and were aged ≥25 years

You may not qualify if:

  • People who had undergone surgery involving removal of their rectum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cancer Screening and Prevention Research Group (CSPRG), Department of Surgery and Cancer, Queen Elizabeth The Queen Mother (QEQM) Building, St Mary's Hospital, Imperial College London

London, W2 1NY, United Kingdom

Location

MeSH Terms

Conditions

Colorectal Neoplasms, Hereditary Nonpolyposis

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsNeoplastic Syndromes, HereditaryDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesDNA Repair-Deficiency DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Limitations and Caveats

Participants were receiving care at four of the best centres for Lynch syndrome in England. We were able to analyse information on check-up colonoscopies only for participants who had a past or current cancer. Data for this study were largely collected before colonoscopy check-up for people living with Lynch syndrome in England moved to the national Bowel Cancer Screening Programme.

Results Point of Contact

Title
Dr Emma Robbins
Organization
Imperial College London

Study Officials

  • Amanda J Cross, PhD

    Imperial College London

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2023

First Posted

November 13, 2023

Study Start

January 17, 2024

Primary Completion

April 4, 2024

Study Completion

December 31, 2024

Last Updated

June 5, 2026

Results First Posted

June 5, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations